Tongshu Gene
Latest round
- Series D
Last raised
- Oct 2024
Total raised
- $92M
Investors
- 10
About Tongshu Gene
Established in 2016 and based in Shanghai, China, Tongshu Gene is a technology company that focuses on tumour gene testing service, providing precise medication, efficacy monitoring, postoperative recurrence monitoring, risk prediction and other services. The company has set up medical clinical inspection centers, Gene Technology Research Institute and a production center in Shanghai and Changzhou, respectively. The CEO, Linghua Yan, is a Vice Chairman of China Genetic Testing Alliance. It self-developed microsatellite instability detection kit received the first Class III medical device registration certificate for MSI testing in January 2021. Tongshu Gene has a full range of ctDNA detection technologies, including core technology packages such as cfTNA extraction, enrichment and PRIDE-cfDNA library building technology. Based on this, the company launched the tumour ctDNA detection platform Diagnostic Heart Safety, a ctDNA core technology systematic solution. It has also launched a microsatellite instability (MSI) detection kit. The company also developed the Oncology Speciality Internet Hospital, a health management platform that can provide video consultations. The company generates revenue by providing tumour precision molecular diagnostic services and detection kits.
Who invested in Tongshu Gene
10 investors across 3 rounds
See all investors in Tongshu Gene
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tongshu Gene
Who invested in Tongshu Gene?
Tongshu Gene has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tongshu Gene raised?
Tongshu Gene has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Tongshu Gene last raise money?
Tongshu Gene's most recent round on record is a Series D, in Oct 2024.
What does Tongshu Gene do?
Established in 2016 and based in Shanghai, China, Tongshu Gene is a technology company that focuses on tumour gene testing service, providing precise medication, efficacy monitoring, postoperative recurrence monitoring, risk prediction and other services.
Where is Tongshu Gene headquartered?
Tongshu Gene is headquartered in Shanghai, China.
Which VCs invest in companies like Tongshu Gene?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Tongshu Gene's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Tongshu Gene? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.